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compare the results of seroepidemio-
logic investigations among cats living
in sites contaminated by avian viruses.
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Pneumonic Plague,
Northern India,
2002
To the Editor: A small outbreak
of primary pneumonic plague took
place in the Shimla District of
Himachal Pradesh State in northern
India during February 2002. Sixteen
cases of plague were reported with a
case-fatality rate of 25% (4/16). The
infection was confirmed to the molec-
ular level with PCR and gene
sequencing (1). A previous outbreak
in this region during 1983 was sug-
gestive of pneumonic plague (22
cases, 17 deaths) but was not con-
firmed. In India, the last laboratory-
confirmed case of plague was report-
ed in 1966 from Karnataka State (2).
The index patient for the 2002
outbreak lived in a hamlet in the
Himalayas. He went hunting on
January 28, 2002, in a nearby forest at
a height of ≈500–600 m from his
house. There, he killed a sick wild cat
and skinned it. He returned home on
February 2 and sought treatment for
fever, chills, and headache. On
February 4, breathlessness, chest pain,
and hemoptysis developed; radiologic
findings were suggestive of lobar
pneumonia, and treatment with aug-
mentin was begun. He died the next
day. Subsequently, 13 of his relatives
exhibited a similar illness, although 2
additional patients acquired infection
in the hospital. The incubation period
for those patients was 1–4 days,
which is consistent with that of pneu-
monic plague.
A team of microbiologists, epi-
demiologists, and entomologists visit-
ed the village after 7 more cases were
reported until February 12, 2002, fol-
lowed by a team from the National
Institute of Communicable Diseases
(NICD), New Delhi. The following
case-patient definition was used: a
person who sought treatment for fever
of rapid onset, chills, chest pain,
breathlessness, headache, prostration,
and hemoptysis. A total of 16 cases
were reported from 3 hospitals in the
area: a local civil hospital, the state
medical college, and a regional terti-
ary care hospital. Clinical material
collected from the case-patients and
their contacts was initially processed
in the laboratories of these hospitals.
Wayson staining provided immediate
presumptive diagnosis, and confirma-
tory tests were performed at NICD.
Diagnosis of plague was confirmed
for 10 (63%) of 16 patients (1).
NICD conducted the following
laboratory tests on 2 suspected culture
isolates, 2 sputum specimens, 1 lung
autopsy material specimen, and 1 lung
lavage sample (Table): 1) direct fluo-
rescent antibody test for Yersinia
pestis; 2) culture and bacteriophage
lysis test; and 3) PCR and gene
sequencing to detect Y.  pestis–specif-
ic genes (pla and F1). All these tests
confirmed that isolates were Y. pestis
and met all the World Health Organi-
zation’s recommended criteria (2). 
Antibodies against F1 antigen of
Y. pestis were detected by passive
hemagglutination testing of paired
serum samples. Although 5 patients
showed a >4-fold rise, 1 patient
showed a >4-fold fall in antibody titer.
In contrast, samples from 6 patients
were negative for Y. pestis, and no
change was found in the titers from 1
patient. No serum sample was collect-
ed from the index patient; for the 2
other patients who died, 1 of the sin-
gle serum samples became contami-
nated, and the other was positive for
Y. pestis (3). Paired serum samples
from the case-patients were collected
on a single day 4 weeks apart during
the visit of the NICD team, regardless
of the duration of symptoms.
Antimicrobial drug sensitivity
testing was carried out by the Kirby-
Bauer disk diffusion method. All iso-
lates were sensitive to doxycycline,
tetracycline, chloramphenicol, strep-
tomycin, ciprofloxacin, gentamicin,
and amikacin but were resistant to
penicillin.
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No fleas or other ectoparasites
were found on the 6 cats, 8 dogs, 6
cows, 4 calves or 2 trapped rodents in
the village. One serum sample, with
pooled blood from 3 dogs was nega-
tive for antibodies against F1 antigen.
Before these infections occurred, a
heavy snowfall in the region had
reduced the activity of rodents and
was unfavorable for the survival and
multiplication of rat fleas. The snow
also helped restrict the spread of the
infection because of reduced move-
ment of the local population (1).
Primary pneumonic plague is
acquired by inhaling infective
droplets from persons or animals and
rarely by accidental aerosol exposure.
Y. pestis is a category A agent of
bioterrorism (4). It is not truly air-
borne; person-to-person transmission
requires face-to-face exposure within
2 m of a coughing patient (2). During
1977–1998, in the western United
States, 23 cases of cat-associated
human plague were reported. Bites,
scratches, or other contact with infec-
tious material while handling infected
cats resulted in 17 cases of bubonic
plague, 1 case of primary septicemic
plague, and 5 cases of primary pneu-
monic plague (5).
In our report, close and pro-
longed contact with the index patient
while providing care (for example,
wiping his face during hemoptysis,
supporting him during a bout of
coughing, taking him to the hospital
in a vehicle) resulted in secondary
cases. Because of the severe winter,
poor ventilation in houses further
helped the illness spread. All patients
acquired infection before plague was
suspected. Initially, patients were
treated for community-acquired pneu-
monia, which delayed the proper
treatment and led to deaths. A patient
admitted for status epilepticus was
infected by her attendant, who in turn,
acquired infection from a terminally
ill plague patient for whom he provid-
ed some care. The patient with epilep-
sy and her attendant shared a common
room with the terminally ill wife of
the index patient, which was small
and poorly ventilated. Surprisingly,
the relative of the index case-patient
who had accompanied him to the for-
est survived the infection; whereas,
the wife and sister of the index patient
died. No spread to healthcare workers
was noted.
When plague was suspected
immediate preventive measures were
taken, for example, fumigation of the
index patient’s residence and any
vehicles used for transporting the
patients; active surveillance and edu-
cation; standard work precautions;
chemoprophylaxis for patient contacts
and paramedics; and isolation and
treatment of patients (1). The trans-
mission rate for primary pneumonic
plague is relatively low compared
with that of many other communica-
ble diseases; the average number of
secondary cases per primary case is
1.3, according to a study done by Gani
and Leach (6).
The key element in the control of
small outbreaks of primary pneumon-
ic plague could be the intensity of dis-
ease surveillance system (6). As a
result, the state government has estab-
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lished a Plague Surveillance Unit in
District Shimla of Himachal Pradesh
in 2002 (1).
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Francisella 
tularensis, Portugal
To the Editor: Tularemia is a
zoonosis caused by Francisella
tularensis. Recently, tularemia has
emerged in new locations, popula-
tions, and settings (1). After an out-
break in Spain in 1997 (2), it was
expected that the disease would
spread toward Portugal, a country
with an extended area that borders the
affected areas.
To evaluate the situation, a sur-
veillance project, including a seroepi-
demiologic study in human popula-
tions and detection of the nucleic acid
of F. tularensis in biologic samples,
was initiated. The district of
Bragança, in northern Portugal, was
selected as study area for its vicinity
with tularemia-endemic areas of
Spain and because Dermacentor retic-
ulatus and  Ixodes ricinus are well
documented there (3).
Biologic samples were collected
from 74 persons living in the study
region whose activities represented an
increased risk for contact with ticks
and wild mammals. Serum samples
were available from 48 and were ana-
lyzed with the microagglutination test
(4). From the other 26 persons, blood
samples were collected and frozen.
Because of hemolization these sam-
ples were only subjected to PCR.
DNA was extracted by using the
QIAamp blood kit (QIAGEN GmbH,
Hilden, Germany).
A total of 110 ticks were collect-
ed from vegetation by using the flag-
ging method (n = 5) or from verte-
brate hosts (n = 105) and were identi-
fied at the species level and processed
individually (5). Of these ticks, 79
were D. reticulatus, 1 I. ricinus, 15 D.
marginatus, 11  Rhipicephalus san-
guineus, and 4 Hyalomma margina-
tum.
A fragment of the gene encoding
the 17-kDa lipoprotein (Tul4) of F.
tularensis was amplified, as described
previously (6). Resulting products
were subjected to electrophoresis on
0.8% low-melt agarose gels (Roche
Diagnostics GmbH, Mannheim,
Germany), and the bands were puri-
fied by using the QIAquick gel extrac-
tion kit (QIAGEN GmbH) and
sequenced with the BigDye
Terminator Cycle Sequencing kit
(Applied Biosystems, Foster City,
CA, USA) on an ABI 377 DNA
sequencer. The sequences were
aligned with other sequences from
databases by using ClustalX (7).
Pairwise distance matrices were
determined by the Kimura 2-parame-
ter method, with MEGA3 software.
Phylogenetic trees were constructed
with the neighbor-joining algorithm,
by using bootstrap analysis with 500
replications for evaluation of the
matrices’ topology. Also, 1 region
with short sequence tandem repeats
(SSTR9) of F. tularensis was ampli-
fied as described previously (8).
Resulting products were subjected to
electrophoresis on a 3% MS-4
agarose gel (Pronadisa, Madrid,
Spain).
The 48 samples studied by serol-
ogy were negative. From the 26
human samples available for PCR, 1
was positive in the amplification of
Tul4, which represented a prevalence
rate of 3.8% of the samples studied.
This result was confirmed by repeat-
ing both the DNA extraction and the
PCR 3×. The amplification of SSTR9
in this case was negative. The differ-
ence between the results of the PCR
methods targeting Tul4 and SSTR9 in
the human sample is not surprising,
since Tul4 PCR has higher sensitivity
than that of SSTR9, which is a
method not optimal for direct use in
clinical samples (8,9). This positive
result was for a 43-year-old man, a
hunter who had frequent contact with
lagomorphs. At the time of the collec-
tion, he was asymptomatic, but a his-
tory of a recent febrile illness was
reported. He also stated that he had no
recent occupational or recreational
exposure in Spain. For the ticks, 1
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